Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma

References

• Gebbia V, Giuliani F, Maiello E, Colucci G, Verderame F, Borsellino N, et al. Treatment of inoperable and/or metastatic biliary tree carcinoma with single agent gemcitabine or in combination with levo-folinic acid and infusional floururacil; results of a multicenter phase II study. J Clin Oncol 2001; 19:4089–91.
   PubMed Web of Science ®Google Scholar
• Kornek GV, Schuell B, Laengle F, Gruenberger T, Penz M, Karall K, et al. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: A randomized phase II trial. Ann Oncol 2004;15:478–83.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Hoffmann K, Sjoden PO, Jacobsson G, Sellstrøm H, Enander LK, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593–600.
   PubMed Web of Science ®Google Scholar
• Rao S, Cunningham D, Hawkins RE, Hill ME, Smith D, Daniel F, et al. Phase III study of 5 FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5 FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer 2005;92:1650–4.
   PubMed Web of Science ®Google Scholar
• Ducreux M, Van Cutsem E, Van Laethem JL, Gress TM, Jeziorski K, Rougier P, et al. A randomized phase II trial of weekly high-dose 5-fluoruracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma. Eur J Cancer 2005;41:398–403.
   PubMed Web of Science ®Google Scholar
• Hollebecque A, Bouche O, Romano O, Scaglia E, Cattan S, Zerbib P, et al. Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma. Chemotherapy 2010;56:234–8.
   PubMed Web of Science ®Google Scholar
• Sohn BS, Yuh YJ, Kim KH, Jeon TJ, Kim NS, Kim SR, et al. Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder and ampulla of Vater. Tumori 2013; 99:139–44.
   PubMed Web of Science ®Google Scholar
• Wu CE, Hsu HC, Shen WC, Lin YC, Wang HM, Chang JW, et al. Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: A retrospective analysis. Chang Gung Med J 2012;35:420–7.
   PubMedGoogle Scholar
• Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: A randomized controlled study. J Clin Oncol 2010;28:4581–6.
   PubMed Web of Science ®Google Scholar
• Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials. Br J Cancer 2007;96:896–902.
   PubMed Web of Science ®Google Scholar
• Valle J, Wasan H, Palmer D, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. New Engl J Med 2010; 362(14):1273–81.
   Web of Science ®Google Scholar
• Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, et al. Gemcitabine combined with oxaliplatin in advanced biliary tract adenocarcinoma: A GERCOR study. Ann Oncol 2004;15:1339–43.
   PubMed Web of Science ®Google Scholar
• Lee J, Park S, Chang H, Kim JS, Choi HJ, Lee MA, et al. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: A multicenter open label randomized phase III study. Lancet 2012;13:181–8.
   PubMed Web of Science ®Google Scholar
• Lassen U, Jensen LH, Sorensen M, Rohrberg KS, Ujmajuridze Z, Jacobsen A, et al. A phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinoma. Acta Oncol 2011;50:448–54.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar